Imerys (NK) investor relations material

Opening remarks and agenda

• The meeting was opened with introductions of key executives and board members, including the new CFO and candidates for board positions.

• Legal formalities for convening the meeting and shareholder notifications were confirmed, with all required documents made available online.

• The agenda included financial performance, governance, strategic initiatives, and voting on resolutions.

Financial performance review

• 2025 revenue was EUR 3,384 million, stable year-over-year, with adjusted EBITDA at EUR 546 million, reflecting strong cost control despite adverse forex impacts.

• Net income was negative EUR 409 million, mainly due to a EUR 467 million goodwill impairment in the RAC segment, with no cash impact.

• Free cash flow before strategic CapEx was EUR 127 million; after CapEx, EUR 78 million, with strategic investments focused on lithium projects.

• Debt increased slightly due to investments and dividends, but net financial debt decreased in the second half of 2025; investment-grade rating was confirmed.

• Q1 2026 saw revenue of EUR 835 million (up 0.7% like-for-like) and adjusted EBITDA of EUR 118 million (up 4% at constant exchange rates).

Board and executive committee updates

• Johannes Huth was co-opted to the board, and Michael Ogrinz was proposed as a new director; several board members stepped down.

• Board independence rate will be 62.5% with the new composition, meeting gender diversity requirements.

• Fatima Bensif joined as an employee representative director.